Format

Send to

Choose Destination
Nat Commun. 2015 Dec 8;6:10049. doi: 10.1038/ncomms10049.

Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant.

Author information

1
Department of Biophysics, Center for Molecular Biomedicine, Friedrich Schiller University Jena &Jena University Hospital, 07745 Jena, Germany.
2
Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305-5208, USA.
3
Department of Genetics, Stanford University School of Medicine, Stanford California 94305-5208, USA.
4
Institute of Human Genetics, Jena University Hospital, 07743 Jena, Germany.
5
Institute of Neuropathology, RWTH Aachen University Hospital, 52074 Aachen, Germany.
6
Cologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany.
7
Institute of Human Genetics, University of Cologne, 50931 Cologne, Germany.
8
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
9
Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany.

Abstract

Gain-of-function mutations in the human SCN11A-encoded voltage-gated Na(+) channel NaV1.9 cause severe pain disorders ranging from neuropathic pain to congenital pain insensitivity. However, the entire spectrum of the NaV1.9 diseases has yet to be defined. Applying whole-exome sequencing we here identify a missense change (p.V1184A) in NaV1.9, which leads to cold-aggravated peripheral pain in humans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel opening to hyperpolarized potentials thereby conferring gain-of-function characteristics to NaV1.9. Mutated channels diminish the resting membrane potential of mouse primary sensory neurons and cause cold-resistant hyperexcitability of nociceptors, suggesting a mechanistic basis for the temperature dependence of the pain phenotype. On the basis of direct comparison of the mutations linked to either cold-aggravated pain or pain insensitivity, we propose a model in which the physiological consequence of a mutation, that is, augmented versus absent pain, is critically dependent on the type of NaV1.9 hyperactivity.

PMID:
26645915
PMCID:
PMC4686659
DOI:
10.1038/ncomms10049
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center